Takeda initiates Ph3 trial for Ixazomib in Asia
China | News | By BioSpectrum Bureau | 0 Comment | 28 Jan, 2014
Singapore: Takeda Development Center Shanghai (TDC Shanghai) and Takeda Development Center Asia has commenced TOURMALINE...Read more
China plans to phase out mandatory cosmetics animal testing
China | News | By BioSpectrum Bureau | 0 Comment | 11 Nov, 2013
Singapore: China's Food and Drug Administration plans to remove its mandatory animal test requirements for domestically ...Read more
China bird flu: Detection of new H7N9 strain is hard
China | News | By BioSpectrum Bureau | 0 Comment | 09 Apr, 2013
Singapore: Since February 2013, more than 20 people in Shanghai in three provinces in China have been infected with the ...Read more
Boehringer to educate heart doctors in China
China | News | By BioSpectrum Bureau | 0 Comment | 12 Mar, 2013
Singapore: Boehringer Ingelheim in co-operation with the American College of Cardiology (ACC) Scientific Sessions launch...Read more
China Pharma's Q2 2014 revenue dips by 24%
China | Company results | By BioSpectrum Bureau | 0 Comment | 19 Aug, 2014
Singapore: China Pharma has marked revenue of USD 6.1 million in the second quarter of 2014, sliding down 24 percent fro...Read more
HUYA, Changzhou to harbour biotech innovation
China | News | By BioSpectrum Bureau | 0 Comment | 19 Aug, 2014
Singapore: China's HUYA Bioscience has struck a partnership with Changzhou Center for Biotech Development (CZCBD) to foc...Read more
Heartbeat reports 350% growth in emerging markets
China | News | By BioSpectrum Bureau | 0 Comment | 07 May, 2013
Singapore: Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry, has ...Read more
WuXi PharmaTech appoints new director
China | Influencers | By BioSpectrum Bureau | 0 Comment | 11 Aug, 2014
‎Singapore: China based R&D service provider, WuXi PharmaTech, has appointed Mr Walter Teh-Ming Kwauk as an in...Read more
Pfizer's Lycria effective in shingles pain: China study
China | News | By BioSpectrum Bureau | 0 Comment | 13 Aug, 2014
Singapore: Global pharmaceutical company, Pfizer, has achieved positive result from its phase 4 study of pain reducing d...Read more
Hong Kong's Luye Pharma acquires Beijing's Jialin
China | News | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2014
Singapore: Hong Kong based-Luye Pharma has entered into an agreement to purchase a majority stake into Beijing's Jialin ...Read more
China reports 436,800 cases of HIV/AIDS in 2013
China | News | By BioSpectrum Bureau | 0 Comment | 18 Aug, 2014
Singapore: China is facing the burden of HIV and AIDS as the country's health authority reported 436,800 people infected...Read more
China firm attracts global talent to boost M&A potential
China | News | By BioSpectrum Bureau | 0 Comment | 03 Aug, 2012
Singapore: China-based GC-Rise Pharmaceutical, in which European healthcare venture capital fund INVENTAGES holds a majo...Read more
GSK-linked investigators will not appeal jail term
China | News | By BioSpectrum Bureau | 0 Comment | 18 Aug, 2014
Singapore: British corporate investigator Mr Peter Humphrey and his American wife Ms Yu Yingzeng have decided to accept ...Read more
Chipscren Biosciences receives CFDA nod
China | News | By BioSpectrum Bureau | 0 Comment | 13 Jan, 2015
Singapore: A Chinese biotech firm, Chipscreen Biosciencees has received the China FDA nod for its flagship drug Epidaza ...Read more
Shortage of Pediatric resources in China
China | News | By BioSpectrum Bureau | 0 Comment | 15 Sep, 2014
Singapore: In a recently held press conference, the National Health and Family Planning Commission (NHFPC) in China decl...Read more
Bloomage BioTech, GIC to invest in China
China | News | By BioSpectrum Bureau | 0 Comment | 09 Nov, 2015
Singapore: Bloomage BioTechnology Corporation ("Bloomage BioTech" or "the Company"; together with its subsidiaries, coll...Read more
Boston Scientific asthma device gets China FDA nod
China | News | By BioSpectrum Bureau | 0 Comment | 30 Oct, 2013
Singapore: Boston Scientific has received China Food and Drug Administration (CFDA) approval for Alair Bronchial Thermop...Read more
Fosun sells ex-China rights of two drugs for $531 mn
China | News | By BioSpectrum Bureau | 0 Comment | 23 Oct, 2013
Singapore: China-based Shanghai Fosun Pharma is planning to sell ex-China rights for two of its drug candidates to Sella...Read more